This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Find Which Dividend Etf Is Best Value by assessing cost, diversification, and proven performance across the dividend ETF landscape.
25,553 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...
Across Latin America, a new wave of fintechs is defying expectations. This article dives into three standout players,...
The first half of 2026 delivered a sharp downturn for Salesforce as AI-driven disruption and market rotation shook th...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
When a company’s founder or CEO sells a chunk of stock, it sparks questions. This article breaks down the Zoom inside...
Investors are torn on Amazon stock as AI hype collides with earnings reality. This guide offers a clear framework to ...
CrossCountry Mortgage pushes back in the bid for Two Harbors, saying a fully financed cash offer backed by Citi will ...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
If federal foreclosure protections vanish, the housing market could see a surge of distressed properties. This articl...
A clear, practical breakdown of DEFT's Q4 2025 results and what the deft 2025 earnings transcript signals for 2026. L...
As Berkshire Hathaway's leadership evolves, investors wonder if berkshire hathaway greg abel has echoed Warren Buffet...